Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-11+69,920→ 69,920 totalExercise: $43.04Exp: 2032-02-11→ Common Stock (69,920 underlying)
Footnotes (1)
- [F1]The securities awarded on February 11, 2022 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 17,480 shares of common stock shall vest on the one year anniversary of February 11, 2022, with 52,440 shares vesting in 36 equal monthly installments thereafter.